Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

1.5K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
1.5K
Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

1.3K
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.3K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

1.1K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.1K
Direct-Acting Cholinergic Agonists: Pharmacological Actions00:59

Direct-Acting Cholinergic Agonists: Pharmacological Actions

2.1K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
2.1K
Cholinergic Antagonists: Pharmacological Actions01:28

Cholinergic Antagonists: Pharmacological Actions

1.5K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.5K
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

2.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intravenous anesthesia; triple valve distributor, without stopcocks, for two or more liquids.

Prensa medica argentina·2010
Same author

Respiratory regulation of splanchnic and systemic venous return in normal subjects and in patients with hepatic cirrhosis.

Surgery, gynecology & obstetrics·1982
Same author

Left ventricular performance in endotoxin shock in dogs.

The American journal of physiology·1982
Same author

Irreversible thermodynamics of an isometric twitch, time-dependent general formulation.

The American journal of physiology·1980
Same author

Rate of generation of myocardial power density normalized by cardiac frequency.

The American journal of physiology·1979
Same author

Respiratory changes in intrapleural and intraperitoneal pressures and their effect upon pressure in the central veins.

The Journal of surgical research·1977
Same journal

Mitochondrial STING Governs Glycolytic Reprogramming in Diabetic Cardiomyopathy.

Circulation research·2026
Same journal

Hypoxia-Induced Epas1-Myl9/12 Axis Shapes the Pathology of Pulmonary Hypertension.

Circulation research·2026
Same journal

Proteogenomics of Hypertrophic Cardiomyopathy Reveals Subtype-Specific Therapy.

Circulation research·2026
Same journal

Impaired Endothelial Cell Cholesterol Metabolism Promotes Vascular Inflammation in Sleep Apnea.

Circulation research·2026
Same journal

Engineered Heart Tissues Facilitate Noncoding Variant Studies in Cardiomyopathy.

Circulation research·2026
Same journal

NUAK1 Inhibition Alleviates Ischemia-Reperfusion Injury via SYNE1-YAP1.

Circulation research·2026
See all related articles

Related Experiment Video

Updated: Dec 18, 2025

Measurement of Endothelium-Dependent Vasorelaxation in the Mouse Thoracic Aorta Using Tensometric Small Volume Chamber Myography
09:47

Measurement of Endothelium-Dependent Vasorelaxation in the Mouse Thoracic Aorta Using Tensometric Small Volume Chamber Myography

Published on: August 12, 2022

3.9K

Methylxanthines in cardiac contractility

A H Moreno

    Circulation Research
    |November 1, 1972
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Contractility Measurements on Isolated Papillary Muscles for the Investigation of Cardiac Inotropy in Mice
    06:22

    Contractility Measurements on Isolated Papillary Muscles for the Investigation of Cardiac Inotropy in Mice

    Published on: September 17, 2015

    15.3K
    Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice
    15:45

    Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice

    Published on: February 10, 2013

    18.6K

    Related Experiment Videos

    Last Updated: Dec 18, 2025

    Measurement of Endothelium-Dependent Vasorelaxation in the Mouse Thoracic Aorta Using Tensometric Small Volume Chamber Myography
    09:47

    Measurement of Endothelium-Dependent Vasorelaxation in the Mouse Thoracic Aorta Using Tensometric Small Volume Chamber Myography

    Published on: August 12, 2022

    3.9K
    Contractility Measurements on Isolated Papillary Muscles for the Investigation of Cardiac Inotropy in Mice
    06:22

    Contractility Measurements on Isolated Papillary Muscles for the Investigation of Cardiac Inotropy in Mice

    Published on: September 17, 2015

    15.3K
    Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice
    15:45

    Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice

    Published on: February 10, 2013

    18.6K